Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Newsummit Biopharma Files for $80 Million NYSE IPO

publication date: Feb 25, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Newsummit Biopharma, a Shanghai-based CRO offering pre-clinical drug development services, filed to raise up to $80 million in a New York Stock Exchange IPO. The company has offices in five technology parks around China, and is headquartered in Shanghai's Zhangjiang Hi-Tech Park. Newsummit aims to be a one-stop solution for bringing a drug candidate or medical device through an IND (or NDA) filing, after the initial work on the product has been completed. The company uses a network of 99 service providers for most tasks. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners